In conclusion, our results suggest that UC-dysplasia, UC-CRC and S-CRC may have different molecular pathways given the higher expression of Reg IV but lower KRAS and P53 expression in patients with UC-CRC in comparison to S-CRC. This evidence concerns the gene KRAS and colorectal carcinoma.